DrugPatentWatch Database Preview
XIAFLEX Drug Profile
Summary for Tradename: XIAFLEX
| Patents: | 10 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for XIAFLEX |
Recent Clinical Trials for XIAFLEX
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Men's Health Boston | Phase 4 |
| Endo Pharmaceuticals | Phase 4 |
| Manhattan Medical Research Practice, PLLC | Phase 4 |
Company Disclosures: US Patents for XIAFLEX
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Auxilium Pharms | XIAFLEX | collagenase clostridium histolyticum | SOLUTION; INJECTION | 125338 | 001 | 2010-02-02 | Start Trial | Advance Biofactures of Curacao (Curacao, AN) | 2039-03-29 | RX | company | |
| Auxilium Pharms | XIAFLEX | collagenase clostridium histolyticum | SOLUTION; INJECTION | 125338 | 001 | 2010-02-02 | Start Trial | Auxilium US Holdings, LLC (Wilmington, DE) | 2026-01-30 | RX | company | |
| Auxilium Pharms | XIAFLEX | collagenase clostridium histolyticum | SOLUTION; INJECTION | 125338 | 001 | 2010-02-02 | Start Trial | Advance Biofactures Corporation (Lynbrook, NY) | 2039-02-26 | RX | company | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for XIAFLEX
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Auxilium Pharms | XIAFLEX | collagenase clostridium histolyticum | SOLUTION; INJECTION | 125338 | 001 | 2010-02-02 | Start Trial | BioSpecifics Technologies Corporation (Lynbrook, NY) Duke University (Durham, NC) | 2033-03-15 | RX | search | |
| Auxilium Pharms | XIAFLEX | collagenase clostridium histolyticum | SOLUTION; INJECTION | 125338 | 001 | 2010-02-02 | Start Trial | Ethicon, Incorporated (Somerville, NJ) | 2023-06-27 | RX | search | |
| Auxilium Pharms | XIAFLEX | collagenase clostridium histolyticum | SOLUTION; INJECTION | 125338 | 001 | 2010-02-02 | Start Trial | Asan Laboratories Company (Cayman) Limited (Taipei, TW) | 2022-04-26 | RX | search | |
| Auxilium Pharms | XIAFLEX | collagenase clostridium histolyticum | SOLUTION; INJECTION | 125338 | 001 | 2010-02-02 | Start Trial | Asan Laboratories Company (Cayman), Limited (Taipei, TW) | 2022-04-26 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for XIAFLEX
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20080093142 | Start Trial |
| European Patent Office | 2379089 | Start Trial |
| Australia | 2012200863 | Start Trial |
| Spain | 2625041 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
